In vitro long-term performance study of a near-infrared fluorescence affinity sensor for glucose monitoring

被引:65
|
作者
Ballerstadt, R
Polak, A
Beuhler, A
Frye, J
机构
[1] BioTex Inc, Houston, TX 77054 USA
[2] Motorola Inc, Northbrook, IL 60062 USA
来源
BIOSENSORS & BIOELECTRONICS | 2004年 / 19卷 / 08期
关键词
diabetes; concanavalin A; dextran; sephadex; Alexa dye; fluorophore; regenerated cellulose acetate membrane;
D O I
10.1016/j.bios.2003.08.019
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The Iona-term in vitro performance of a fluorescence affinity sensor for transdermal blood glucose monitoring was investigated. Affinity binding of fluorescently labeled concanavalin A (ConA) was used in this application, as previously described by Ballerstadt and Schultz [Anal. Chem. 17 (2000) 4185-4192]. In this paper, the fluorescence emission of the sensor was extended to the near infrared (670 nm) using Alexa647(TM) as the fluorochrome conjugated to concanavalin A. Sensors were alternately exposed to glucose solutions having concentrations of 2.5 and 20 mM with a dwell time of 3 h. The optical output of the sensors was monitored over a 4-month period. The sensors showed an initial increase in fluorescence over the first 3-4 weeks before gradually decreasing, with an approximately linear drop of 25% per month. In order to understand the reasons for the decrease in fluorescence output, further experiments were conducted, including time-dependent membrane leakage tests. solubility tests of ConA, temperature-dependent activity tests of ConA, and fluorescence photo-bleaching tests. From these results. it became evident that the decrease in fluorescence was not due to denaturation of the ConA. The most likely cause was leakage of the fluorescently labeled ConA through the interface between the outer sealant and the membrane. This problem is considered to be solvable and future publications will address this issue. Extrapolation of the experimental data suggests that a leak-proof sensor would be remarkably stable with a fluorescence decrease of only 15% over a 1-year period. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:905 / 914
页数:10
相关论文
共 50 条
  • [41] Rationale, design, and method of the Diabetes & Women's Health study - a study of long-term health implications of glucose intolerance in pregnancy and their determinants
    Zhang, Cuilin
    Hu, Frank B.
    Olsen, Sjurdur F.
    Vaag, Allan
    Gore-Langton, Robert
    Chavarro, Jorge E.
    Bao, Wei
    Yeung, Edwina
    Bowers, Katherine
    Grunnet, Louise G.
    Sherman, Seth
    Kiely, Michele
    Strom, Marin
    Hansen, Susanne
    Liu, Aiyi
    Mills, James
    Fan, Ruzong
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2014, 93 (11) : 1123 - 1130
  • [42] Long-term Change in Physiological Markers and Cognitive Performance in Type 2 Diabetes: The Look AHEAD Study
    Carmichael, Owen T.
    Neiberg, Rebecca H.
    Dutton, Gareth R.
    Hayden, Kathleen M.
    Horton, Edward
    Pi-Sunyer, F. Xavier
    Johnson, Karen C.
    Rapp, Stephen R.
    Spira, Adam P.
    Espeland, Mark A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (12):
  • [43] Long-term glucose variability and incident cardiovascular diseases and all-cause mortality events in subjects with and without diabetes: Tehran Lipid and Glucose Study
    Barzegar, Niloofar
    Ramezankhani, Azra
    Tohidi, Maryam
    Azizi, Fereidoun
    Hadaegh, Farzad
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 178
  • [44] Long-Term Cost-Effectiveness the Dexcom G6 Real-Time Continuous Glucose Monitoring System Compared with Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in France
    Roze, Stephane
    Isitt, John J.
    Smith-Palmer, Jayne
    Lynch, Peter
    Klinkenbijl, Brigitte
    Zammit, Gerald
    Benhamou, Pierre-Yves
    DIABETES THERAPY, 2021, 12 (01) : 235 - 246
  • [45] Reduction of clinically important low glucose excursions with a long-term implantable continuous glucose monitoring system in adults with type 1 diabetes prone to hypoglycaemia: the France Adoption Randomized Clinical Trial
    Renard, Eric
    Riveline, Jean-Pierre
    Hanaire, Helene
    Guerci, Bruno
    DIABETES OBESITY & METABOLISM, 2022, 24 (05): : 859 - 867
  • [46] Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada
    Roze, Stephane
    Isitt, John J.
    Smith-Palmer, Jayne
    Lynch, Peter
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2021, 13 : 717 - 725
  • [47] Long-Term Effects of Initiating Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring (CGM) in People with Type 1 Diabetes and Unsatisfactory Diabetes Control
    Senn, Jon-Duri
    Fischli, Stefan
    Slahor, Lea
    Schelbert, Susanne
    Henzen, Christoph
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (03)
  • [48] Long-Term Effect of the Color Record Method in Self-Monitoring of Blood Glucose on Metabolic Parameters in Type 2 Diabetes: A 2-Year Follow-up of the Color IMPACT Study
    Nishimura, Akiko
    Harashima, Shin-ichi
    Hosoda, Kiminori
    Inagaki, Nobuya
    DIABETES THERAPY, 2018, 9 (04) : 1501 - 1510
  • [49] Long-term Effects of Remote Patient Monitoring in Patients Living with Diabetes: A Retrospective Look at Participants of the Mississippi Diabetes Telehealth Network Study
    Davis, Tearsanee Carlisle
    Allen, Ashley S.
    Zhang, Yunxi
    TELEMEDICINE REPORTS, 2022, 3 (01): : 130 - 136
  • [50] Impact of long-term glucose variability on coronary atherosclerosis progression in patients with type 2 diabetes: a 2.3 year follow-up study
    Li, Suhua
    Tang, Xixiang
    Luo, Yanting
    Wu, Bingyuan
    Huang, Zhuoshan
    Li, Zexiong
    Peng, Long
    Ling, Yesheng
    Zhu, Jieming
    Zhong, Junlin
    Liu, Jinlai
    Chen, Yanming
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)